Study to compare effect of Trinpanchmoola Kashaya and Dhatryadi Kashaya in Chronic Kidney Disease

A Comparative Clinical Study to Evaluate the Efficacy of Trinpanchmoola Kashaya and Dhatryadi Kashaya in the Management of Chronic Kidney Disease - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100833

Enrollment

Registered

2026-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in the trial. 2. Patients between the age group of 30-70 yrs will be selected for the study. 3. Patients who present with sign and symptoms of CKD. 4. Patients of chronic renal failure fulfilling following criteria. a. Blood Urea - 40-100 mg /dl. b. S. creatinine - 1.3-5.0 mg/dl. c. eGFR - 45-90 ml/min/1.73m2.

Exclusion criteria

Exclusion criteria: 1. Patient not willing to participate in trial. 2. Patients with Fasting Blood Sugar more than 165mg per dl and Blood Pressure more than 140 by 90mmHg. 3. Patients in advanced renal failure, with B. Urea more than 100mg per dl, S. creatinine more than 5.0 mg per dl and eGFR less than 45ml per min per 1.73m2. 4. Patients suffering from other major illness like Carcinoma and Pulmonary Tuberculosis or any other condition considered to be unfit for enrolment in the trial. 5. Patients with Obstructed Uropathy, Nephrectomy. 6. Individuals who have completed participation in any other clinical trial during the past three months. 7. Any other condition which the principal investigator thinks may jeopardize the study

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the effect of Trinpanchmool Kashaya and Dhatryadi Kashaya in the management of CKD.Timepoint: 60 days	—

Secondary

Measure	Time frame
To assess the safety profile and untoward effects of Trinpanchmool Kashaya and Dhatryadi Kashaya in CKD patients.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactSakshi Sharma

Rajiv Gandhi Government Post Graduate Ayurvedic College & Hospital Paprola Distt. Kangra 176115

dharmanidrgetika@gmail.com9418054049

Outcome results